An aqueous injectable suspension uses moxidectin microspheres and isoxazoline particles to extend parasite control while reducing injection site irritation.
A short-course KAF156 regimen maintains parasiticidal serum levels against resistant malaria while simplifying dosing and improving adherence.
A plant cell culture route boosts and purifies tormentic acid ester production to deliver lower-toxicity antitrypanosomal compositions.
A synthetic Sm14 gene with AOX1 and GAP promoters boosts Pichia pastoris yield while avoiding methanol-driven cost and stability limits.